Outcome
    Strong Evidence
    Effectiveness 4/5

    St. Johns Wort for Depression Symptom Reduction

    St John's Wort matches SSRIs for mild-to-moderate depression, but its drug interactions are the deciding factor for most people.

    Overview

    Verdict

    Strong yes

    Cochrane evidence across 5,489 participants shows Hypericum extracts beat placebo and match standard antidepressants with better tolerability, though a large US trial was null and effect sizes vary sharply by trial region.

    How It Works

    Downstream effects

    Hyperforin inhibits monoamine reuptake via sodium gradient disruption
    Affects serotonin, noradrenaline, dopamine, GABA and glutamate
    Hypericin and flavonoids add receptor and anti-inflammatory activity
    Activates the pregnane X receptor
    Induces CYP3A4 and P-glycoprotein, accelerating drug clearance

    Dosing & Protocol

    Doses used in human trials

    PopulationDoseScheduleNotes
    Adults, mild to moderate depression300 mg standardised extractThree times dailyThe classic trial regimen; 900 mg per day total
    Higher-dose arms600-1,800 mg dailyDivided or once dailyUsed in some comparator trials against antidepressants
    Standardisation0.3 percent hypericin or 3-5 percent hyperforinPer labelProducts vary widely; unstandardised preparations were not what was trialled
    Severe depressionNot establishedNot appropriate for self-treatmentTrial data are weakest here and specialist care is needed

    Effects build over weeks. Trials generally ran 4 to 12 weeks before assessing response.

    Simple protocol

    1. 1

      Check your medication list first

      This is the step that matters most. St Johns wort interacts with contraceptives, anticoagulants, antidepressants, immunosuppressants, HIV and cancer drugs.

    2. 2

      Choose a standardised extract

      Look for standardisation to hypericin or hyperforin; that is what the trials used.

    3. 3

      Take 300 mg three times daily· 4-6 weeks minimum

      With food. Consistency matters more than timing.

    4. 4

      Use sun protection

      Photosensitivity is dose-related, particularly in fair-skinned people.

    5. 5

      Review at 6 weeks

      If symptoms have not improved, seek clinical assessment rather than escalating the dose.

    6. 6

      Taper rather than stop abruptly

      Discontinuation symptoms have been reported, and stopping also reverses the enzyme induction, which can raise levels of other drugs.

    Evidence

    Studies linked to this pairing.

    Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial

    Score: 9/10
    2002
    rct
    n=340

    Hypericum Depression Trial Study Group

    St John's wort was not effective for moderately severe major depression in this trial.

    View source

    St John's wort for major depression

    Score: 9/10
    2008
    systematic_review
    n=5489

    Linde K, Berner MM, Kriston L

    St John's wort is effective for mild to moderate major depression with better tolerability than standard antidepressants.

    View source
    Pooled participants
    5,489 across the Cochrane review
    Comparison with antidepressants
    Similar efficacy with fewer adverse-effect dropouts
    Contradicting trial
    340-participant JAMA trial where neither Hypericum nor sertraline beat placebo
    Regional variation
    Trials from German-speaking countries reported larger effects
    Trial dose
    Usually 900 mg standardised extract daily in divided doses
    Main limitation
    Heterogeneous extracts, uncertain benefit in severe depression, and extensive drug interactions

    Safety

    Depression needs proper care

    Do not use St Johns wort in place of assessment or prescribed treatment, and never stop an antidepressant to switch to it. Suicidal thoughts, severe depression or bipolar disorder require urgent clinical help.

    Interactions & Conflicts

    Interactions and cautions

    Interacts withSeverityMechanismAction
    Hormonal contraceptives
    high
    CYP3A4 induction lowers hormone levelsContraceptive failure is documented; use another method or avoid the herb
    SSRIs, SNRIs and triptans
    high
    Additive serotonergic activityDo not combine; risk of serotonin syndrome
    Warfarin and direct oral anticoagulants
    high
    Accelerated clearance reduces anticoagulationAvoid; INR destabilisation is well documented
    Ciclosporin, tacrolimus and HIV antiretrovirals
    high
    Enzyme and transporter induction lowers drug levelsAvoid; transplant rejection and treatment failure reported
    Bipolar disorder
    high
    Antidepressant activity can precipitate maniaOnly under psychiatric supervision
    Sun exposure and phototherapy
    low
    Dose-related photosensitivityUse sun protection

    References

    1. Linde K et al. St Johns wort for major depression. Cochrane Database Syst Rev (2008)
    2. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum in major depressive disorder: a randomized controlled trial. JAMA (2002)
    3. MHRA - St Johns wort interactions guidance

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.